1,581
Views
0
CrossRef citations to date
0
Altmetric
Review

A systemic analysis of Creutzfeldt Jakob disease cases in Asia

, , , ORCID Icon &
Pages 11-27 | Received 20 Oct 2023, Accepted 25 Jan 2024, Published online: 07 Feb 2024

References

  • Ironside JW, Ritchie DL, Head MW. Prion diseases. Handb Clin Neurol. 2017;145:393–403. doi: 10.1016/B978-0-12-802395-2.00028-6
  • Iwasaki Y. Creutzfeldt-Jakob disease. Neuropathology. 2017;37(2):174–188. doi: 10.1111/neup.12355
  • Caughey B, Baron GS. Prions and their partners in crime. Nature. 2006;443(7113):803–810. doi: 10.1038/nature05294
  • Linden R, Martins VR, Prado MA, et al. Physiology of the prion protein. Physiol Rev. 2008;88(2):673–728. doi: 10.1152/physrev.00007.2007
  • Linden R, Cordeiro Y, Lima LM. Allosteric function and dysfunction of the prion protein. Cell Mol Life Sci. 2012;69(7):1105–1124. doi: 10.1007/s00018-011-0847-7
  • Laurén J, Gimbel DA, Nygaard HB, et al. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature. 2009;457(7233):1128–1132. doi: 10.1038/nature07761
  • Zanusso G, Monaco S, Pocchiari M, et al. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease. Nat Rev Neurol. 2016;12(6):325–333. doi: 10.1038/nrneurol.2016.65
  • Manix M, Kalakoti P, Henry M, et al. Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus. 2015;39(5):E2. doi: 10.3171/2015.8.FOCUS15328
  • Ladogana A, Puopolo M, Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586–1591. doi: 10.1212/01.WNL.0000160117.56690.B2
  • Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66(1):213–239. doi: 10.1093/bmb/66.1.213
  • Pocchiari M, Puopolo M, Croes EA, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2003;127(10):2348–2359. doi: 10.1093/brain/awh249
  • Alperovitch A, Zerr I, Pocchiari M, et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet. 1999;353(9165):1673–1674. doi: 10.1016/s0140-6736(99)01342-2
  • Mead S, Stumpf MP, Whitfield J, et al. Balancing selection at the prion protein gene consistent with prehistoric kuru like epidemics. Science. 2003;300(5619):640–643. doi: 10.1126/science.1083320
  • Puoti G, Bizzi A, Forloni G, et al. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012;11(7):618–628. doi: 10.1016/S1474-4422(12)70063-7
  • Ladogana A, Kovacs GG. Genetic Creutzfeldt-Jakob disease. Handb Clin Neurol. 2018;153:219–242. doi: 10.1016/B978-0-444-63945-5.00013-1
  • Capellari S, Strammiello R, Saverioni D, et al. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol. 2011;121(1):21–37. doi: 10.1007/s00401-010-0760-4
  • Mastrianni JA. The genetics of prion diseases. Genet Med. 2010;12(4):187–195. doi: 10.1097/GIM.0b013e3181cd7374
  • Duffy P, Wolf J, Collins G, et al. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974;290(12):692–693. https://pubmed.ncbi.nlm.nih.gov/4591849/
  • Holman RC, Belay ED, Christensen KY, et al. Human prion diseases in the United States. PLos One. 2010;5(1):e8521. doi: 10.1371/journal.pone.0008521
  • Brown P, Brandel JP, Sato T, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18(6):901–907. doi: 10.3201/eid1806.120116
  • Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt 10):2659–2668. doi: 10.1093/brain/awp191
  • Smith PS PP. Creutzfeldt-Jackob Disease-Eighteenth Annual Report. 2009; https://www.cjd.ed.ac.uk/sites/default/files/report18
  • Uttley L, Carroll C, Wong R, et al. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2–e10. doi: 10.1016/S1473-3099(19)30615-2
  • Guo YP, Yang YC, Zhang XG, et al. Virus-induced subacute spongiform encephalopathy (creutzfeldt-jakob disease): a report of two Chinese cases with clinico-pathologic studies. J Neurol. 1986;73(2):137–44. doi: 10.1016/0022-510x(86)90125-5
  • Zhao W, Zhang JT, Xing XW, et al. Chinese specific characteristics of sporadic Creutzfeldt-Jakob disease: a retrospective analysis of 57 cases. PLos One. 2013;8(3):e58442. doi: 10.1371/journal.pone.0058442
  • Shi Q, Gao C, Zhou W, et al. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007. BMC Public Health. 2008;8(1):360. doi: 10.1186/1471-2458-8-360
  • Shi Q, Zhou W, Chen C, et al. Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016. Prion. 2016;10(6):484–491. doi: 10.1080/19336896.2016.1229731
  • Qi C, Zhang JT, Zhao W, et al. Sporadic Creutzfeldt-Jakob disease: a retrospective analysis of 104 cases. Eur Neurol. 2020;83(1):65–72. doi: 10.1159/000507189
  • Chan YW, Ho HC, Kay CS, et al. Creutzfeldt-Jakob disease in Hong Kong. A case report. J Neurol Sci. 1987;80(2–3):143–152. doi: 10.1016/0022-510x(87)90150-x
  • Mead S, Knight R. Fact sheet: genetic CJD. CJD Support Network. 2022;2:5.
  • Satish CP, Shankar SK. Creutzfeldt-Jakob disease in India (1971-1990). Neuroepidemiology. 1991;10(1):27–32. doi: 10.1159/000110244
  • Biswas A, Khandelwal N, Pandit A, et al. Case series of probable sporadic Creutzfeldt-Jakob disease from Eastern India. Ann Indian Acad Neurol. 2013;16(4):659–663. doi: 10.4103/0972-2327.120486
  • Yamada M, Nozaki I, Hamaguchi T, et al. シンポジウム11―2 プリオン病の最新トピックス プリオン病サーベイランスの現状と成果. Clin Neurol. 2019;49(11):939–942. doi: 10.5692/clinicalneurol.49.939
  • Iwasaki Y, Mimuro M, Yoshida M, et al. Survival to akinetic mutism state in Japanese cases of MM1-type sporadic Creutzfeldt-Jakob disease is similar to Caucasians. Eur J Neurol. 2011;18(7):999–1002. doi: 10.1111/j.1468-1331.2010.03185.x
  • Kosami K, Ae R, Hamaguchi T, et al. Methionine homozygosity for PRNP polymorphism and susceptibility to human prion diseases. J Neurol Neurosurg Psychiatry. 2022;93(7):779–784. doi: 10.1136/jnnp-2021-328720
  • Hisata Y, Yamashita S, Tago M, et al. Heidenhain Variant of Sporadic Creutzfeldt-Jakob disease with a variety of visual symptoms: a case report with autopsy study. Am J Case Rep. 2023;24:e938654–1. doi: 10.12659/ajcr.938654
  • Scrimgeour EM, Chand PR, Kenny K, et al. Creutzfeldt-Jakob disease in Oman: report of two cases. J Neurol Sci. 1996;142(1–2):148–150. doi: 10.1016/0022-510x(96)00171-2
  • Ahmad A, Rao F, Aieshah S. Two cases of Creutzfeldt-Jakob disease from an ongoing dementia registry in Pakistan. J Pak Med Assoc. 2014;64(6):705–707. https://pubmed.ncbi.nlm.nih.gov/25252497/
  • Khan S, Khan S. Sporadic Creutzfeldt-Jakob disease: diagnosing typical and atypical presentations under limited circumstances. Dement Geriatr Cognit Disord. 2011;50(1):36–42. doi: 10.1159/000514470
  • . Shahid R, Shafqat S. Biopsy proven case of Creutzfeldt- Jacob disease from Pakistan. Pakistan J Neurol Sci (PJNS). 2017;13. https://ecommons.aku.edu/pjns/vol13/iss1/9
  • See SJ, Pan A, Seah A, et al. Case reports of two biopsy-proven patients with Creutzfeldt-Jakob disease in Singapore. Ann Acad Med Singap. 2004;33(5):651–655. https://pubmed.ncbi.nlm.nih.gov/15531964/
  • Sun Y, Fan LY, Te HC, et al. Prognostic features of sporadic Creutzfeldt-Jakob disease: an analysis of Taiwan’s nationwide surveillance. J Am Med Dir Assoc. 2022;23(5):845–851. doi: 10.1016/j.jamda.2021.08.010
  • Lolekha P, Rasheed A, Yotsarawat C. Creutzfeldt-Jakob disease in a tertiary care hospital in Thailand: a case series and review of the literature. J Mov Disord. 2015;8(3):136. doi: 10.14802/jmd.15014
  • Shi Q, Chen C, Xiao K, et al. Genetic prion disease: insight from the features and experience of China national surveillance for Creutzfeldt-Jakob disease. Neurosci Bull. 2021;37(11):1570–1582. doi: 10.1007/s12264-021-00764-y
  • Shi Q, Chen C, Xiao K, et al. Characteristics of different types of prion diseases - China’s surveillance. Chin CDC Weekly. 2022;4(33):723–728. doi: 10.46234/ccdcw2022.151
  • Shi Q, Zhou W, Chen C, et al. Rare genetic Creutzfeldt-Jakob disease with T188K mutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients. JNNP. 2017;88(10):889–890. doi: 10.1136/jnnp-2016-314868
  • Chen C, Shi Q, Zhou W, et al. Clinical and familial characteristics of eight Chinese patients with T188K genetic Creutzfeldt-Jakob disease. Infect Genet Evol. 2013;14(1):120–124. doi: 10.1016/j.meegid.2012.11.019
  • Capellari S, Strammiello R, Saverioni D, et al. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol. 2011;121(1):21–37. doi: 10.1007/s00401-010-0760-4
  • Gao LP, Shi Q, Xiao K, et al. The genetic Creutzfeldt-Jakob disease with E200K mutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients. Sci Rep. 2019;9(1):1–7. doi: 10.1038/s41598-019-38520-y
  • Gao C, Shi Q, Zhou W, et al. The first Chinese case of Creutzfeldt-Jakob disease with mutation of E200K in PRNP. Biomed Environ Sci. 2010;23(2):158–160. doi: 10.1016/s0895-3988(10)60046-3
  • Shi Q, Zhou W, Chen C, et al. Rare E196A mutation in PRNP gene of 3 Chinese patients with creutzfeldt-jacob disease. Prion. 2016;10(4):331–337. doi: 10.1080/19336896.2016.1190897
  • Shi Q, Xiao K, Chen C, et al. Characteristics of Chinese patients with genetic CJD who have E196A or E196K mutation in PRNP: comparative analysis of patients identified in the Chinese national CJD surveillance system. BMJ Open. 2021;11(11):e054551. doi: 10.1136/bmjopen-2021-054551
  • Zhang H, Wang M, Wu L, et al. Novel prion protein gene mutation at codon 196 (E196A) in a septuagenarian with Creutzfeldt–Jakob disease. J Clin Neurosci. 2014 Jan 1;21(1):175–178. doi: 10.1016/j.jocn.2013.03.016
  • Shi Q, Chen C, Song XN, et al. A Chinese Creutzfeldt-Jakob disease patient with E196K mutation in PRNP. Prion. 2011;5(2):117–120. doi: 10.4161/pri.5.2.15846
  • Shi Q, Chen C, Wang XJ, et al. Rare V203I mutation in the PRNP gene of a Chinese patient with Creutzfeldt-Jakob disease. Prion. 2013;7(3):259–262. doi: 10.4161/pri.24674
  • Chen C, Shi Q, Tian C, et al. The first Chinese case of Creutzfeldt-Jakob disease patient with R208H mutation in PRNP. Prion. 2011;5(3):232–234. doi: 10.4161/pri.5.3.16796
  • Shi Q, Shen XJ, Zhou W, et al. Rare V180I mutation in PRNP gene of a Chinese patient with Creutzfeldt-Jakob disease. Prion. 2014;8(6):411–414. doi: 10.4161/19336896.2014.967040
  • Chandra S, Mahadevan A, Shankar S, et al. A brief commentary. Ann Indian Acad Neurol. 2019;22(4):462–463. doi: 10.4103/aian.AIAN_508_19
  • Sawal N, Chakravarty K, Puri I, et al. Familial Creutzfeldt-Jakob disease: the first reported kindred from South-East Asia. Ann Indian Acad Neurol. 2019;22(2):225–227. doi: 10.4103/aian.AIAN_441_18
  • Katrak S, Pauranik A, Desai S, et al. Familial Creutzfeldt-Jakob Disease in an Indian Kindred. Ann Indian Acad Neurol. 2019;22(4):458–461. doi: 10.4103/aian.AIAN_214_19
  • Hoque MZ, Kitamoto T, Furukawa H, et al. Mutation in the prion protein gene at codon 232 in Japanese patients with Creutzfeldt-Jakob disease: a clinicopathological, immunohistochemical and transmission study. Acta Neuropathol. 1996;92(5):441–446. doi: 10.1007/s004010050544
  • Nakamaura Y, Ae R, Takumi I, et al. Descriptive epidemiology of prion disease in Japan: 1999-2012. J Epidemiol. 2015;25(1):8–14. doi: 10.2188/jea.JE20140022
  • Seno H, Tashiro H, Ishino H, et al. New haplotype of familial Creutzfeldt-Jakob disease with a codon 200 mutation and a codon 219 polymorphism of the prion protein gene in a Japanese family. Acta Neuropathol. 2000;99(2):125–130. doi: 10.1007/PL00007415
  • Qina T, Sanjo N, Hizume M, et al. Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open. 2014;4(5):4968. doi: 10.1136/bmjopen-2014-004968
  • Sanjo N, Tsukamoto T, Furukawa F, et al. Human prion diseases in Japan: a prospective surveillance from 1999. J Neurol Sci. 2015;357:e137. doi: 10.1016/j.jns.2015.08.438
  • Kim YC, Jeong BH. Creutzfeldt-Jakob disease incidence, South Korea, 2001–2019. Emerg Infect Dis. 2022;28(9):1863. doi: 10.3201/eid2809.212050
  • Choi BY, Kim SY, Seo SY, et al. Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients. BMC Infect Dis. 2009;9(1):132. doi: 10.1186/1471-2334-9-132
  • Il YT, Jung DS, Ahn BY, et al. Familial Creutzfeldt-Jakob disease with V180I mutation. J Korean Med Sci. 2010;25(7):1097–1100. doi: 10.3346/jkms.2010.25.7.1097
  • Ryoo N, Yi SH, An SSA, et al. A creutzfeldt–Jakob disease patient with V180I mutation survived for 16.5 years after diagnosis. Acta Neurol Belg. 2022;122(1):249–250. doi: 10.1007/s13760-021-01850-8
  • Lee SM, Chung M, Hyeon JW, et al. Genomic characteristics of genetic Creutzfeldt-Jakob disease patients with V180I mutation and associations with other neurodegenerative disorders. PLoS One. 2016;11(6):e0157540. doi: 10.1371/journal.pone.0157540
  • Sun Y, Liu CC, Fan LY, et al. Incidence of and mortality due to human prion diseases in Taiwan: a prospective 20-year nationwide surveillance study from 1998 to 2017. Clin Epidemiol. 2020;12:1073–1081. doi: 10.2147/CLEP.S274093
  • Chi NF, Lee YC, Lu YC, et al. Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan. J Neurol. 2010;257(2):191–197. doi: 10.1007/s00415-009-5290-4
  • Tanaka S, Fukushima M. Size of creutzfeldt-jakob disease epidemic associated with cadaveric dura transplantation. Neuroepidemiology. 2010 May;34(4):232–237. doi: 10.1159/000297747
  • Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, et al. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease. Neurology. 2007 Jul;69(4):360–367. doi: 10.1212/01.wnl.0000266624.63387.4a
  • Hamaguchi T, Sakai K, Noguchi-Shinohara M, et al. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J Neurol Neurosurg Psychiatry. 2013;84(10):1171–1175. doi: 10.1136/jnnp-2012-304850
  • Nakamura Y, Yanagawa H, Hoshi K, et al. Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol. 1999 Feb;28(1):130–134. doi: 10.1093/ije/28.1.130
  • Ae R, Hamaguchi T, Nakamura Y, et al. Update: dura mater graft-associated Creutzfeldt-Jakob disease - Japan, 1975-2017. MMWR Morb Mortal Wkly Rep. 2018 Mar;67(9):274–278. doi: 10.15585/mmwr.mm6709a3
  • Hamaguchi T, Noguchi-Shinohara M, Nozaki I, et al. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology. 2009;29(5):625–631. doi: 10.1111/j.1440-1789.2009.01023.x
  • Lai CH, Tseng HF. Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt-Jakob disease and multiple sclerosis. Neuroepidemiology. 2009;33(3):247–253. doi: 10.1159/000229779
  • Watson N, Brandel JP, Green A, et al. The importance of ongoing international surveillance for creutzfeldt–Jakob disease. Nat Rev Neurol. 2021;17(6):362–379. doi: 10.1038/s41582-021-00488-7
  • Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133(10):3043–3057. doi: 10.1093/brain/awq216
  • Gao C, Shi Q, Tian C, et al. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One. 2011;6(8):e24231. doi: 10.1093/brain/awq216
  • Jeong BH, Nam JH, Lee YJ, et al. Polymorphisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet. 2004;49(6):319–324. doi: 10.1007/s10038-004-0150-7
  • Brown P, Brandel JP, Sato T, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18(6):901. doi: 10.3201/eid1806.120116
  • Bonda DJ, Manjila S, Mehndiratta P, et al. Human prion diseases: surgical lessons learned from iatrogenic prion transmission. Neurosurg Focus. 2016;41(1):E10. doi: 10.3171/2016.5.FOCUS15126
  • Baiardi S, Rossi M, Capellari S, et al. Recent advances in the histo‐molecular pathology of human prion disease. Brain Pathol. 2019;29(2):278–300. doi: 10.1111/bpa.12695
  • Kim MO, Takada LT, Wong K, et al. Genetic PrP prion diseases. Cold Spring Harb Perspect Biol. 2018;10(5):a033134. doi: 10.1101/cshperspect.a033134
  • Li HF, Liu ZJ, Dong HL, et al. Clinical features of Chinese patients with Gerstmann–sträussler–scheinker identified by targeted next-generation sequencing. Neurobiol Aging. 2017;49:216–e1. doi: 10.1016/j.neurobiolaging.2016.09.018
  • Long L, Cai X, Shu Y, et al. A family with hereditary cerebellar ataxia finally confirmed as gerstmann-sträussler-scheinker syndrome with P102L mutation in PRNP gene. Neurosci J. 2017;22(2):138–142. doi: 10.17712/nsj.2017.2.20160522
  • Wang J, Xiao K, Zhou W, et al. Analysis of 12 Chinese patients with proline-to-leucine mutation at codon 102-associated gerstmann-sträussler-scheinker disease. J Clin Neurol. 2019;15(2):184–90. doi: 10.3988/jcn.2019.15.2.184
  • Shi Q, Chen C, Xiao K, et al. Genetic prion disease: insight from the features and experience of China national surveillance for Creutzfeldt-Jakob disease. Neurosci Bull. 2021;37(11):1570–82. doi: 10.1007/s12264-021-00764-y
  • Shi Q, Zhou W, Chen C, et al. The features of genetic prion diseases based on Chinese surveillance program. PLoS One. 2015;10(10):e0139552. doi: 10.1371/journal.pone.0139552
  • Kim DY, Shim KH, Bagyinszky E, et al. Prion mutations in republic of republic of Korea, China, and Japan. Int J Mol Sci. 2022;24(1):625. doi: 10.3390/ijms24010625
  • Iwasaki Y, Kizawa M, Hori N, et al. A case of gerstmann-sträussler-scheinker syndrome with the P105L prion protein gene mutation presenting with ataxia and extrapyramidal signs without spastic paraparesis. Clin Neurol Neurosur. 2009;111(7):606–9. doi: 10.1016/j.clineuro.2009.03.008
  • Saitoh Y, Ogawa M, Naito Y, et al. Discordant clinicopathologic phenotypes in a Japanese kindred of fatal familial insomnia. Neurology. 2010;74(1):86–9. doi: 10.1212/WNL.0b013e3181c7da09
  • Park MJ, Jo HY, Cheon SM, et al. A case of gerstmann-sträussler-scheinker disease. J Clin Neurol. 2010;6(1):46–50. doi: 10.3988/jcn.2010.6.1.46
  • Moe Lee S, Ran Ju Y, Choi BY, et al. Genotype patterns and characteristics of PRNP in the Korean population. Prion. 2012;6(4):375–82. doi: 10.4161/pri.20195
  • Kang MJ, Suh J, An SS, et al. Pearls & Oy-sters: Challenging diagnosis of Gerstmann-Sträussler-Scheinker disease: Clinical and imaging findings. Neurology. 2019;92(2):101–103. doi: 10.1212/WNL.0000000000006730
  • Ahn SJ, Lee HS, Moon J, et al. First familial cases of P102L Gerstmann–sträussler–scheinker syndrome in South Korea: diffusion-weighted imaging might reflect intrafamilial phenotypic variability. Neurol Sci. 2022;43(5):3419–22. doi: 10.1007/s10072-022-05927-x
  • Lee MJ, Shin J, Chung EJ, et al. Midbrain hypometabolism in fatal familial insomnia: a case report and a statistical parametric mapping analysis of a Korean family. Case Rep In Neurol. 2014;6(3):243–250. doi: 10.1159/000365412
  • Yang TW, Park B, Kim KT, et al. Fatal familial insomnia presenting with agrypnia excitata and very low atonia index level: a case report and literature review. Medicine. 2018;97(18):e0646. doi: 10.1097/MD.0000000000010646
  • Bhatia S, Bijarnia-Mahay S, Dubey S, et al. Familial prion disease: first indian kindred with gerstmann–sträussler–scheinker syndrome. Neurol India. 2020;68(6):1431. doi: 10.4103/0028-3886.304068
  • Shi Q, Zhou W, Chen C, et al. The features of genetic prion diseases based on Chinese surveillance program. PLos One. 2015;10(10):e0139552. doi: 10.1371/journal.pone.0139552
  • Kovács GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118(2):166–174. doi: 10.1007/s00439-005-0020-1